FDA Warning Letter — HANDELNINE GLOBAL LLP

Case 716013 — FEI 3020035045

The FDA took a Warning Letter action against HANDELNINE GLOBAL LLP on November 17, 2025 (Mumbai, India). The action was issued by CDER and concerns drugs products.

Action Details

Facility
HANDELNINE GLOBAL LLP
Date
November 17, 2025
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Mumbai (India)